- This e-mail (and any attachment hereto) are private and confidential and may contain proprietary or privileged information. If you are not the intended recipient or have received this e-mail in error, (i) you are hereby informed that any use, review, retransmission, dissemination, disclosure, copying or other use of this e-mail and the information it contains is strictly prohibited; and (ii) please notify the sender and immediately delete/destroy all copies (electronic or otherwise) of this e-mail and all attachments.
- Duopharma Biotech Berhad [Registration No: 200001021664 (524271-W)] (“Duopharma Biotech”) and its subsidiary, associate and affiliate corporations reserve the right to monitor all email communications through its networks.
- Duopharma Biotech and its subsidiary, associate and affiliate corporations (collectively “Duopharma Biotech Group”) do not guarantee that emails and attachments are virus free. E-mail transmission also cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete. Duopharma Biotech Group therefore does not accept any liability whatsoever in respect of any viruses or other interfering or damaging elements or computer problems experienced nor any errors or omissions in the contents of this email, which arise as a result of this form of communication.
- Any views or opinions presented in this email are solely those of the author and do not necessarily represent those of Duopharma Biotech Group. Employees and officers of the Duopharma Biotech Group are expressly required not to make defamatory statements and not to infringe or authorise any infringement of copyright or any other legal right by email communications. Any such communication is contrary to Duopharma Biotech Group policy and outside the scope of the employment of the individual concerned. Duopharma Biotech Group will not accept any liability in respect of such communication, and the employee responsible will be personally liable for any damages, penalties or other liability arising.
- Contracts may only be concluded on behalf of any member of Duopharma Biotech Group with another party by that member’s authorised signatories and not by email communication.
- If verification of the contents of this email is required, please request a hard-copy version.
- This Email Disclaimer is applicable to all emails sent or purported to be sent by, through or via any email server(s), networks(s), service(s), system(s), application(s) or account(s) belonging or licensed to, or otherwise operated, used or authorised by or on behalf of Duopharma Biotech and/or any of its subsidiary, associate or affiliate corporations.